Status:
COMPLETED
Immune Suppression Of Infants Treated With Steroids
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Hemangioma
Eligibility:
All Genders
Up to 6 years
Brief Summary
The goal of this study is to clarify the degree of immune suppression in infants requiring therapy and to create guidelines for evaluation and prevention of infection in infants on oral steroids for h...
Detailed Description
Infants with large or complicated hemangiomas are often treated systemically with oral steroids. The side effects of the drug on young infants has not been studied. The goal of this study is to clarif...
Eligibility Criteria
Inclusion
- Infants \< 6 months of age with infantile hemangiomas requiring treatment with oral corticosteroids
- Infant must be enrolled prior to initiation of steroid therapy
Exclusion
- Infants \> 6 months of age
- Infants already receiving oral corticosteroid treatment prior to the start of this study
- Infants with know immunodeficiencies
- Infants receiving other oral medications for the treatment of hemangiomas
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00433940
Start Date
October 1 2006
End Date
July 1 2010
Last Update
January 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States, 53226